메뉴 건너뛰기




Volumn 546, Issue 1-3, 2006, Pages 82-87

The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of l-DOPA in MPTP treated common marmosets

Author keywords

Adenosine A2a receptor antagonist; MPTP treated primate; Parkinson's disease; ST1535

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2 BUTYL 9 METHYL 8 (2H 1,2,3 TRIAZOL 2 YL) 9H PURIN 6 YLAMINE; ADENOSINE A2A RECEPTOR ANTAGONIST; ANTIPARKINSON AGENT; CARBIDOPA; LEVODOPA; ST 1535; UNCLASSIFIED DRUG; 2 N BUTYL 9 METHYL 8 (1,2,3)TRIAZOL 2 YL 9H PURIN 6 YLAMINE; 2-N-BUTYL-9-METHYL-8-(1,2,3)TRIAZOL-2-YL-9H-PURIN-6-YLAMINE; ADENINE; ADENOSINE A2A RECEPTOR; DRUG DERIVATIVE; TRIAZOLE DERIVATIVE;

EID: 33748457136     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.07.017     Document Type: Article
Times cited : (61)

References (35)
  • 3
    • 3242765264 scopus 로고    scopus 로고
    • Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats
    • Coccurello R., Breysse N., and Amalric M. Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats. Neuropsychopharmacology 29 (2004) 1451-1461
    • (2004) Neuropsychopharmacology , vol.29 , pp. 1451-1461
    • Coccurello, R.1    Breysse, N.2    Amalric, M.3
  • 4
    • 0030615062 scopus 로고    scopus 로고
    • Adenosine A2A receptor antagonism potentiates l-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats
    • Fenu S., Pinna A., Ongini E., and Morelli M. Adenosine A2A receptor antagonism potentiates l-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol. 321 (1997) 143-147
    • (1997) Eur. J. Pharmacol. , vol.321 , pp. 143-147
    • Fenu, S.1    Pinna, A.2    Ongini, E.3    Morelli, M.4
  • 5
    • 25444444802 scopus 로고    scopus 로고
    • Interactions between adenosine A(2a) and dopamine D2 receptors in the control of [(3)H]GABA release in the globus pallidus of the rat
    • Floran B., Gonzalez B., Floran L., Erlij D., and Aceves J. Interactions between adenosine A(2a) and dopamine D2 receptors in the control of [(3)H]GABA release in the globus pallidus of the rat. Eur. J. Pharmacol. 520 (2005) 43-50
    • (2005) Eur. J. Pharmacol. , vol.520 , pp. 43-50
    • Floran, B.1    Gonzalez, B.2    Floran, L.3    Erlij, D.4    Aceves, J.5
  • 7
    • 0344052684 scopus 로고    scopus 로고
    • Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
    • Grondin R., Bedard P.J., Hadj T.A., Gregoire L., Mori A., and Kase H. Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology 52 (1999) 1673-1677
    • (1999) Neurology , vol.52 , pp. 1673-1677
    • Grondin, R.1    Bedard, P.J.2    Hadj, T.A.3    Gregoire, L.4    Mori, A.5    Kase, H.6
  • 8
    • 0035783949 scopus 로고    scopus 로고
    • Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats
    • Hauber W., Neuscheler P., Nagel J., and Muller C.E. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats. Eur. J. Neurosci. 14 (2001) 1287-1293
    • (2001) Eur. J. Neurosci. , vol.14 , pp. 1287-1293
    • Hauber, W.1    Neuscheler, P.2    Nagel, J.3    Muller, C.E.4
  • 9
    • 22344455811 scopus 로고    scopus 로고
    • Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience
    • Hauser R.A., and Schwarzschild M.A. Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience. Drugs Aging 22 (2005) 471-482
    • (2005) Drugs Aging , vol.22 , pp. 471-482
    • Hauser, R.A.1    Schwarzschild, M.A.2
  • 10
    • 0043126954 scopus 로고    scopus 로고
    • Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD
    • Hauser R.A., Hubble J.P., and Truong D.D. Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD. Neurology 61 (2003) 297-303
    • (2003) Neurology , vol.61 , pp. 297-303
    • Hauser, R.A.1    Hubble, J.P.2    Truong, D.D.3
  • 11
    • 0035087868 scopus 로고    scopus 로고
    • Parkinson's disease therapy: treatment of early and late disease
    • Jankovic J. Parkinson's disease therapy: treatment of early and late disease. Chin. Med. J. (Engl.) 114 (2001) 227-234
    • (2001) Chin. Med. J. (Engl.) , vol.114 , pp. 227-234
    • Jankovic, J.1
  • 12
    • 21244440664 scopus 로고    scopus 로고
    • Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease
    • Jenner P. Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease. Expert Opin. Investig. Drugs 14 (2005) 729-738
    • (2005) Expert Opin. Investig. Drugs , vol.14 , pp. 729-738
    • Jenner, P.1
  • 14
    • 0344230823 scopus 로고    scopus 로고
    • Actions of adenosine antagonists in primate model of Parkinson's disease
    • Kase H., Richardson P.J., and Jenner P. (Eds), Academic Press, San Diego
    • Kanda T., and Jenner P. Actions of adenosine antagonists in primate model of Parkinson's disease. In: Kase H., Richardson P.J., and Jenner P. (Eds). Adenosine Receptors and Parkinson's Disease (2000), Academic Press, San Diego 211-227
    • (2000) Adenosine Receptors and Parkinson's Disease , pp. 211-227
    • Kanda, T.1    Jenner, P.2
  • 15
    • 0031594271 scopus 로고    scopus 로고
    • Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys
    • Kanda T., Jackson M.J., Smith L.A., Pearce R.K., Nakamura J., Kase H., Kuwana Y., and Jenner P. Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann. Neurol. 43 (1998) 507-513
    • (1998) Ann. Neurol. , vol.43 , pp. 507-513
    • Kanda, T.1    Jackson, M.J.2    Smith, L.A.3    Pearce, R.K.4    Nakamura, J.5    Kase, H.6    Kuwana, Y.7    Jenner, P.8
  • 16
    • 0032563388 scopus 로고    scopus 로고
    • Adenosine A2A receptors modify motor function in MPTP-treated common marmosets
    • Kanda T., Tashiro T., Kuwana Y., and Jenner P. Adenosine A2A receptors modify motor function in MPTP-treated common marmosets. NeuroReport 9 (1998) 2857-2860
    • (1998) NeuroReport , vol.9 , pp. 2857-2860
    • Kanda, T.1    Tashiro, T.2    Kuwana, Y.3    Jenner, P.4
  • 17
    • 0034049544 scopus 로고    scopus 로고
    • Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys
    • Kanda T., Jackson M.J., Smith L.A., Pearce R.K., Nakamura J., Kase H., Kuwana Y., and Jenner P. Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys. Exp. Neurol. 162 (2000) 321-327
    • (2000) Exp. Neurol. , vol.162 , pp. 321-327
    • Kanda, T.1    Jackson, M.J.2    Smith, L.A.3    Pearce, R.K.4    Nakamura, J.5    Kase, H.6    Kuwana, Y.7    Jenner, P.8
  • 18
    • 0035404473 scopus 로고    scopus 로고
    • New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia
    • Kase H. New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia. Biosci. Biotechnol. Biochem. 65 (2001) 1447-1457
    • (2001) Biosci. Biotechnol. Biochem. , vol.65 , pp. 1447-1457
    • Kase, H.1
  • 19
    • 0034711582 scopus 로고    scopus 로고
    • Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats
    • Koga K., Kurokawa M., Ochi M., Nakamura J., and Kuwana Y. Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats. Eur. J. Pharmacol. 408 (2000) 249-255
    • (2000) Eur. J. Pharmacol. , vol.408 , pp. 249-255
    • Koga, K.1    Kurokawa, M.2    Ochi, M.3    Nakamura, J.4    Kuwana, Y.5
  • 20
    • 0027991686 scopus 로고
    • Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release
    • Kurokawa M., Kirk I.P., Kirkpatrick K.A., Kase H., and Richardson P.J. Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release. Br. J. Pharmacol. 113 (1994) 43-48
    • (1994) Br. J. Pharmacol. , vol.113 , pp. 43-48
    • Kurokawa, M.1    Kirk, I.P.2    Kirkpatrick, K.A.3    Kase, H.4    Richardson, P.J.5
  • 22
    • 0034667715 scopus 로고    scopus 로고
    • A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease
    • Nash J.E., and Brotchie J.M. A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease. J. Neurosci. 20 (2000) 7782-7789
    • (2000) J. Neurosci. , vol.20 , pp. 7782-7789
    • Nash, J.E.1    Brotchie, J.M.2
  • 23
    • 0141744657 scopus 로고    scopus 로고
    • Present and future directions in the management of motor complications in patients with advanced PD
    • Olanow C.W. Present and future directions in the management of motor complications in patients with advanced PD. Neurology 61 (2003) S24-S33
    • (2003) Neurology , vol.61
    • Olanow, C.W.1
  • 24
    • 0029417121 scopus 로고
    • Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus)
    • Pearce R.K., Jackson M., Smith L., Jenner P., and Marsden C.D. Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus). Mov. Disord. 10 (1995) 731-740
    • (1995) Mov. Disord. , vol.10 , pp. 731-740
    • Pearce, R.K.1    Jackson, M.2    Smith, L.3    Jenner, P.4    Marsden, C.D.5
  • 25
    • 0029666492 scopus 로고    scopus 로고
    • Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats
    • Pinna A., di Chiara C.G., Wardas J., and Morelli M. Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats. Eur. J. Neurosci. 8 (1996) 1176-1181
    • (1996) Eur. J. Neurosci. , vol.8 , pp. 1176-1181
    • Pinna, A.1    di Chiara, C.G.2    Wardas, J.3    Morelli, M.4
  • 26
    • 17444413762 scopus 로고    scopus 로고
    • New adenosine A2A receptor antagonists: actions on Parkinson's disease models
    • Pinna A., Volpini R., Cristalli G., and Morelli M. New adenosine A2A receptor antagonists: actions on Parkinson's disease models. Eur. J. Pharmacol. 512 (2005) 157-164
    • (2005) Eur. J. Pharmacol. , vol.512 , pp. 157-164
    • Pinna, A.1    Volpini, R.2    Cristalli, G.3    Morelli, M.4
  • 27
    • 0034856088 scopus 로고    scopus 로고
    • The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors
    • Popoli P., Pezzola A., Torvinen M., Reggio R., Pintor A., Scarchilli L., Fuxe K., and Ferre S. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology 25 (2001) 505-513
    • (2001) Neuropsychopharmacology , vol.25 , pp. 505-513
    • Popoli, P.1    Pezzola, A.2    Torvinen, M.3    Reggio, R.4    Pintor, A.5    Scarchilli, L.6    Fuxe, K.7    Ferre, S.8
  • 28
    • 13244264871 scopus 로고    scopus 로고
    • Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum
    • Rodrigues R.J., Alfaro T.M., Rebola N., Oliveira C.R., and Cunha R.A. Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J. Neurochem. 92 (2005) 433-441
    • (2005) J. Neurochem. , vol.92 , pp. 433-441
    • Rodrigues, R.J.1    Alfaro, T.M.2    Rebola, N.3    Oliveira, C.R.4    Cunha, R.A.5
  • 29
    • 33748465835 scopus 로고    scopus 로고
    • Rose, S., Croft, N., Jenner, P., in press. The novel adenosine antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in unilaterally 6-OHDA lesioned rats. Brain Res.
  • 30
    • 0026326607 scopus 로고
    • Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study
    • Schiffmann S.N., Jacobs O., and Vanderhaeghen J.J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57 (1991) 1062-1067
    • (1991) J. Neurochem. , vol.57 , pp. 1062-1067
    • Schiffmann, S.N.1    Jacobs, O.2    Vanderhaeghen, J.J.3
  • 32
    • 0029989550 scopus 로고    scopus 로고
    • An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets
    • Smith L., De Salvia S.M., Jenner P., and Marsden C.D. An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. Mov. Disord. 11 (1996) 125-135
    • (1996) Mov. Disord. , vol.11 , pp. 125-135
    • Smith, L.1    De Salvia, S.M.2    Jenner, P.3    Marsden, C.D.4
  • 33
    • 33748446549 scopus 로고    scopus 로고
    • Stasi, M., Borsini, F., Varani, K., Vincenzi, F., Di Cesare, M., Minetti, P., Ghirardi, O., Carminati, P., in press. ST1535: A preferential A2a adenosine receptor antagonist. Int. J. Neuropsychopharm. [Epublication ahead of print].
  • 34
    • 0041659345 scopus 로고    scopus 로고
    • Prevention and treatment of motor fluctuations
    • Stocchi F. Prevention and treatment of motor fluctuations. Parkinsonism Relat. Disord. 9 Suppl 2 (2003) S73-S81
    • (2003) Parkinsonism Relat. Disord. , vol.9 , Issue.SUPPL. 2
    • Stocchi, F.1
  • 35
    • 0005866578 scopus 로고    scopus 로고
    • Selective adenosine A2a receptor antagonism as an alternative therapy for Parkinson's disease: a study in non-human primates
    • Kase H., Richardson P.J., and Jenner P. (Eds), Academic Press, San Diego
    • Tadj Tahar A., Grondin R., Gregoire L., and Bedard P.J. Selective adenosine A2a receptor antagonism as an alternative therapy for Parkinson's disease: a study in non-human primates. In: Kase H., Richardson P.J., and Jenner P. (Eds). Adenosine Receptors and Parkinson's Disease (2000), Academic Press, San Diego 229-244
    • (2000) Adenosine Receptors and Parkinson's Disease , pp. 229-244
    • Tadj Tahar, A.1    Grondin, R.2    Gregoire, L.3    Bedard, P.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.